Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
- December |
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
- 2012 -
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
December 2012 - 75 products
IP
CI
Sumatriptan Spirig HC
6
16.85
34.75
10 %
Tablets: Sumatriptanum 50 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Sumatriptan Spirig HC
12
33.62
53.00
10 %
Tablets: Sumatriptanum 50 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Montelukast-Mepha 4 mg
28 Tablet(s)
16.79
34.70
10 %
Chewing tablets: Montelukastum 4 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
Montelukast-Mepha 4 mg
98 Tablet(s)
58.62
80.15
10 %
Chewing tablets: Montelukastum 4 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
Montelukast-Mepha 5 mg
28 Tablet(s)
16.79
34.70
10 %
Chewing tablets: Montelukastum 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
Montelukast-Mepha 5 mg
98 Tablet(s)
58.62
80.15
10 %
Chewing tablets: Montelukastum 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
Docetaxel Fresenius i.v. 80
mg/4 ml
Durchstechflasche(n)
189.64
222.65
10 %
Concentrate for infusion: Docetaxelum 80mg / 4ml
Fresenius Kabi
(Schweiz) AG
A / SL / SG
FB
G
IP
Docetaxel Fresenius i.v. 160
mg/8 ml
Durchstechflasche(n)
379.28
428.90
10 %
Concentrate for infusion: Docetaxelum 160mg / 8ml
Fresenius Kabi
(Schweiz) AG
A / SL / SG
FB
G
IP
Docetaxel Fresenius i.v. 20
mg/1 ml
Durchstechflasche(n)
47.41
68.00
10 %
Concentrate for infusion: Docetaxelum 20 mg/ml
Fresenius Kabi
(Schweiz) AG
A / SL / SG
FB
G
IP
Montelukast-Mepha 10 mg
28 Tablet(s)
16.79
34.70
10 %
Coated tablets: Montelukastum 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
Montelukast-Mepha 10 mg
98 Tablet(s)
58.62
80.20
10 %
Coated tablets: Montelukastum 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
CM
Clindamycin-Mepha 150
16 Capsule(s)
7.71
17.60
10 %
Capsules: Clindamycinum 150 mg
Mepha Pharma AG
A / SL / SG
FB
G
IP
CI
CM
Clindamycin-Mepha 300
16 Capsule(s)
11.76
29.20
10 %
Capsules: Clindamycinum 300 mg
Mepha Pharma AG
A / SL / SG
FB
G
IP
CI
Nebivolol Zentiva
28
4.83
14.50
10 %
Tablets: Nebivololum 5 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Nebivolol Zentiva
98
14.20
31.85
10 %
Tablets: Nebivololum 5 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Ropinirol Sandoz Retard 2 mg
28 Tablet(s)
16.50
34.35
10 %
Tablette mit veränderter Wirkstofffreisetzung: Ropinirolum 2 mg
Sandoz
Pharmaceuticals AG
● 
B / SL / SG
FB
G
IP
CI
Ropinirol Sandoz Retard 4 mg
28 Tablet(s)
29.31
48.25
10 %
Tablette mit veränderter Wirkstofffreisetzung: Ropinirolum 4 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Ropinirol Sandoz Retard 8 mg
28 Tablet(s)
47.71
68.30
10 %
Tablette mit veränderter Wirkstofffreisetzung: Ropinirolum 8 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
PP
Fycompa 2mg
7 Tablet(s)
20.84
39.10
10 %
Coated tablets: Perampanelum Anhydricum 2 mg
Eisai Pharma AG
B / SL
FB
G
L
IP
CI
PP
Fycompa 4mg
28 Tablet(s)
135.87
164.20
10 %
Coated tablets: Perampanelum Anhydricum 4 mg
Eisai Pharma AG
B / SL
FB
G
L
IP
CI
PP
Fycompa 6mg
28 Tablet(s)
135.87
164.20
10 %
Coated tablets: Perampanelum Anhydricum 6 mg
Eisai Pharma AG
B / SL
FB
G
L
IP
CI
PP
Fycompa 8mg
28 Tablet(s)
135.87
164.20
10 %
Coated tablets: Perampanelum Anhydricum 8 mg
Eisai Pharma AG
B / SL
FB
G
L
IP
CI
PP
Fycompa 10mg
28 Tablet(s)
135.87
164.20
10 %
Coated tablets: Perampanelum Anhydricum 10 mg
Eisai Pharma AG
B / SL
FB
G
L
IP
CI
PP
Fycompa 12mg
28 Tablet(s)
135.87
164.20
10 %
Coated tablets: Perampanelum Anhydricum 12 mg
Eisai Pharma AG
B / SL
FB
G
L
IP
CI
Kombiglyze XR 5 mg/ 500 mg
28 Tablet(s)
37.57
57.30
10 %
Coated tablets: 2 Active Agents
AstraZeneca AG
B / SL
FB
G
L
IP
CI
Kombiglyze XR 5 mg/ 500 mg
98 Tablet(s)
131.50
159.45
10 %
Coated tablets: 2 Active Agents
AstraZeneca AG
B / SL
FB
G
L
IP
CI
Kombiglyze XR 2.5 mg/1000 mg
56 Tablet(s)
37.57
57.30
10 %
Coated tablets: 2 Active Agents
AstraZeneca AG
B / SL
FB
G
L
IP
CI
Kombiglyze XR 2.5 mg/1000 mg
196 Tablet(s)
131.50
159.45
10 %
Coated tablets: 2 Active Agents
AstraZeneca AG
B / SL
FB
G
L
IP
CI
Kombiglyze XR 5 mg/1000 mg
28 Tablet(s)
37.57
57.30
10 %
Coated tablets: 2 Active Agents
AstraZeneca AG
B / SL
FB
G
L
IP
CI
Kombiglyze XR 5 mg/1000 mg
98 Tablet(s)
131.50
159.45
10 %
Coated tablets: 2 Active Agents
AstraZeneca AG
B / SL
FB
G
L
IP
CI
PP
Jakavi 5 mg
56 Tablet(s)
1584.82
1740.00
10 %
Tablets: Ruxolitinibum 5 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
PP
Jakavi 10 mg
56 Tablet(s)
3143.42
3435.05
10 %
Tablets: Ruxolitinibum 10 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
PP
Jakavi 15 mg
56 Tablet(s)
3143.42
3435.05
10 %
Tablets: Ruxolitinibum 15 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
PP
Jakavi 20 mg
56 Tablet(s)
3143.42
3435.05
10 %
Tablets: Ruxolitinibum 20 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
Plenadren 5 mg
50
228.83
265.30
10 %
Tabletten mit veränderter Wirkstofffreisetzung: Hydrocortisonum 5 mg
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
Plenadren 20 mg
50
522.65
584.85
10 %
Tabletten mit veränderter Wirkstofffreisetzung: Hydrocortisonum 20 mg
Takeda Pharma AG
B / SL
FB
G
IP
CM
Clindamycin [Phosphat]-
Mepha i.v./i.m. 600 mg/4 ml
5 1 ampoule(s) à 4 ml
PR
PR
k.A.
Injection solution: Clindamycinum 600mg / 4ml
Mepha Pharma AG
A
FB
G
IP
CM
Clindamycin [Phosphat]-
Mepha i.v./i.m. 600 mg/4 ml
25 1 ampoule(s) à 4 ml
PR
PR
k.A.
Injection solution: Clindamycinum 600mg / 4ml
Mepha Pharma AG
A
FB
G
IP
Docetaxel Fresenius i.v. 120
mg/6 ml
Durchstechflasche(n)
382.13
455.10
k.A.
Concentrate for infusion: Docetaxelum 120mg / 6ml
Fresenius Kabi
(Schweiz) AG
A
FB
G
IP
Docetaxel Fresenius i.v. 180
mg/9 ml
Durchstechflasche(n)
690.41
809.00
k.A.
Concentrate for infusion: Docetaxelum 180mg / 9ml
Fresenius Kabi
(Schweiz) AG
A
FB
G
IP
CI
PP
Fycompa 2mg
28 Tablet(s)
PR
PR
k.A.
Coated tablets: Perampanelum Anhydricum 2 mg
Eisai Pharma AG
B
FB
G
IP
CI
PP
Fycompa 4mg
7 Tablet(s)
PR
PR
k.A.
Coated tablets: Perampanelum Anhydricum 4 mg
Eisai Pharma AG
B
FB
G
IP
CI
PP
Fycompa 6mg
7 Tablet(s)
PR
PR
k.A.
Coated tablets: Perampanelum Anhydricum 6 mg
Eisai Pharma AG
B
FB
G
IP
CI
PP
Fycompa 8mg
7 Tablet(s)
PR
PR
k.A.
Coated tablets: Perampanelum Anhydricum 8 mg
Eisai Pharma AG
B
FB
G
IP
CI
PP
Fycompa 10mg
7 Tablet(s)
PR
PR
k.A.
Coated tablets: Perampanelum Anhydricum 10 mg
Eisai Pharma AG
B
FB
G
IP
CI
PP
Fycompa 12mg
7 Tablet(s)
PR
PR
k.A.
Coated tablets: Perampanelum Anhydricum 12 mg
Eisai Pharma AG
B
FB
G
IP
CI
PP
Jakavi 5 mg
3 x 56 Tablet(s)
PR
PR
k.A.
Tablets: Ruxolitinibum 5 mg
Novartis Pharma
Schweiz AG
A
FB
G
IP
CI
PP
Jakavi 10 mg
3 x 56 Tablet(s)
PR
PR
k.A.
Tablets: Ruxolitinibum 10 mg
Novartis Pharma
Schweiz AG
A
FB
G
IP
CI
PP
Jakavi 15 mg
3 x 56 Tablet(s)
PR
PR
k.A.
Tablets: Ruxolitinibum 15 mg
Novartis Pharma
Schweiz AG
A
FB
G
IP
CI
PP
Jakavi 20 mg
3 x 56 Tablet(s)
PR
PR
k.A.
Tablets: Ruxolitinibum 20 mg
Novartis Pharma
Schweiz AG
A
FB
G
H
Traumeel
50 Tablet(s)
PR
PR
k.A.
Tablets: 14 Active Agents
ebi-pharm ag
D
FB
G
H
Traumeel
250 Tablet(s)
PR
PR
k.A.
Tablets: 14 Active Agents
ebi-pharm ag
D
FB
G
IP
CI
Plenadren 5 mg
50 Tablet(s)
PR
PR
k.A.
Tabletten mit veränderter Wirkstofffreisetzung: Hydrocortisonum 5 mg
Takeda Pharma AG
B
FB
G
IP
CI
Plenadren 20 mg
50 Tablet(s)
PR
PR
k.A.
Tabletten mit veränderter Wirkstofffreisetzung: Hydrocortisonum 20 mg
Takeda Pharma AG
B
FB
G
CI
H
Traumeel
30 ml
PR
PR
k.A.
Tropfen zum Einnehmen: 14 Active Agents
ebi-pharm ag
D
FB
G
IP
CI
Xalos-Duo
2.5 ml
15.87
34.60
10 %
Eye drops: 2 Active Agents
medano ag in
Liquidation
B / SL / SG
FB
G
IP
CI
Xalos-Duo
3 x 2.5 ml
46.65
69.95
10 %
Eye drops: 2 Active Agents
medano ag in
Liquidation
B / SL / SG
FB
G
IP
Paracetamol B. Braun 500
mg/50ml
10 1 Durchstechflasche(n) à 50 ml
PR
PR
k.A.
Infusion solution: Paracetamolum 500mg / 50ml
B. Braun Medical AG
B
FB
G
IP
Paracetamol B. Braun 1000
mg/100ml
10 1 Durchstechflasche(n) à 100 ml
PR
PR
k.A.
Infusion solution: Paracetamolum
B. Braun Medical AG
B
FB
G
IP
Gemcitabin DRAC 200mg
Durchstechflasche(n)
PR
PR
k.A.
DRAC AG
A
FB
G
IP
Gemcitabin DRAC 1g
Durchstechflasche(n)
PR
PR
k.A.
DRAC AG
A
FB
G
IP
Gemcitabin DRAC 2g
Durchstechflasche(n)
PR
PR
k.A.
DRAC AG
A
FB
G
Mirjanne 20
21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
Mirjanne 20
3 x 21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
Mirjanne 20
6 x 21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
Mirjanne 30
21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
Mirjanne 30
3 x 21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
Mirjanne 30
6 x 21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Galantamin-Mepha retard 8 mg
7 Capsule(s)
PR
PR
k.A.
Capsules: Galantaminum 8 mg
Mepha Pharma AG
B
FB
G
IP
CI
Galantamin-Mepha retard 8 mg
28 Capsule(s)
PR
PR
k.A.
Capsules: Galantaminum 8 mg
Mepha Pharma AG
B
FB
G
IP
CI
Galantamin-Mepha retard 16 mg
28 Capsule(s)
PR
PR
k.A.
Capsules: Galantaminum 16 mg
Mepha Pharma AG
B
FB
G
IP
CI
Galantamin-Mepha retard 16 mg
84 Capsule(s)
PR
PR
k.A.
Capsules: Galantaminum 16 mg
Mepha Pharma AG
B
FB
G
IP
CI
Galantamin-Mepha retard 24 mg
28 Capsule(s)
PR
PR
k.A.
Capsules: Galantaminum 24 mg
Mepha Pharma AG
B
FB
G
IP
CI
Galantamin-Mepha retard 24 mg
84 Capsule(s)
PR
PR
k.A.
Capsules: Galantaminum 24 mg
Mepha Pharma AG
B
FB
G
Ph
Weber's Pastilles
Halspastillen Cassis
110 g
PR
PR
k.A.
Halspastille: 2 Active Agents
F. Hunziker + Co AG
E
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home